Fig. 2

Incidence-based medical cost per patient, 2013–2016. a Anal, oropharyngeal, penile, vaginal and vulvar cancer. Incidence-based medical cost per patient in 2013–2016 of anal, oropharyngeal (including base of tongue, tonsil), penile, vaginal and vulvar cancer. All costs were adjusted by the medical care component of the Consumer Price Index in 2016. For the first year after diagnosis, the incidence-based cost per patient was highest in oropharyngeal cancer and lowest in penile cancer. In all five cancers, the incidence-based cost per patient increased between 2013 and 2016. b Anal and oropharyngeal cancer by gender. Differences in incidence-based medical cost per patient of anal cancer and oropharyngeal cancer according to gender. Oropharyngeal cancer demonstrated consistently higher results for males than for females during 2013–2016 for medical cost per patient. Anal cancer did not differ significantly between genders